BiotechTube
Home/Pipeline/Veto Cell Therapy for Type‑1 Diabetes

Veto Cell Therapy for Type‑1 Diabetes

Autoimmune Diabetes

PreclinicalActive

Key Facts

Indication
Autoimmune Diabetes
Phase
Preclinical
Status
Active
Company
Cell Source

About Cell Source

Innovative Veto Cell platform enabling donor‑free transplants and durable CAR‑T cancer therapies.

View full company profile

Therapeutic Areas

OncologyHematologyTransplantationAutoimmune